NOVEL TREATMENT OPTIONS IN THE SEVERE β‐GLOBIN DISORDERS
- 1 October 1995
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 91 (2) , 263-268
- https://doi.org/10.1111/j.1365-2141.1995.tb05288.x
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Sickle Cell Anemia — Basic Research Reaches the ClinicNew England Journal of Medicine, 1995
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched BloodNew England Journal of Medicine, 1990
- Hematologic Responses of Patients with Sickle Cell Disease to Treatment with HydroxyureaNew England Journal of Medicine, 1990
- Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell DiseaseNew England Journal of Medicine, 1988
- Stimulation of Fetal Hemoglobin Synthesis by Erythropoietin in BaboonsNew England Journal of Medicine, 1987
- Stimulation of F-Cell Production in Patients with Sickle-Cell Anemia Treated with Cytarabine or HydroxyureaNew England Journal of Medicine, 1985
- Delay in the Fetal Globin Switch in Infants of Diabetic MothersNew England Journal of Medicine, 1985
- Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.Journal of Clinical Investigation, 1984